Chief Executive Officer of French artificial heart manufacturer Carmat, Stephane Piat, poses holding an artificial heart during an interview with Reuters in Velizy, near Paris
French artificial heartmaker Carmat (ALCAR.PA) announced on Tuesday that it had carried out the first implant of its Aeson artificial heart in a woman.
The company said the procedure had been performed at the UofL Health - Jewish Hospital by University of Louisville physicians in the United States.
"This third implant in the U.S. was a landmark event not only because it allowed us to finalize the enrollment of the first cohort of patients of the EFS (early feasibility study), but very importantly because it is the first time ever that our device has helped a woman suffering from heart failure," Carmat CEO Stephane Piat said in a statement.
Reporting by Matthieu Protard; Editing by Sudip Kar-Gupta
Grace period for expats to correct legal status begins today
Recruit a Project Officer for Jobs in Qatar with This Outsourcing Service
Umrah and prayer at Grand Mosque permits restricted for fully vaccinated pilgrims from Oct. 10
Philippine Nobel winner Ressa calls Facebook 'biased against facts'
Pfizer: Know all about the Covid-19 vaccine and its usage in Qatar
FIFA’22 over Covid-19: Qatar limbers up for the World Cup amidst a worldwide pandemic
Top 5 Art Galleries You Must Explore in Qatar
Afghan Women Speaks on Unyielding Hope of Restoring Their Homeland